EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

ADELAIDE, South Australia, Sept. 24, 2024 /PRNewswire/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug developer EnGeneIC Pty Ltd., for a project including technology transfer, process…